Skanska signs contract with Seagen to build facility in Washington, USA for $215 million

Press release 8/4/2023 7:00 AM EST

Skanska has finalized a contract with Seagen to construct a 269,097 square-foot biomanufacturing facility for the global biotechnology company. The facility will include manufacturing, storage, shipping, office and café space in Everett, Washington, USA. The contract is worth $215 M, which will be included in the U.S. order bookings for the third quarter, 2023.

Seagen announced their plans to build the project in April 2022. Construction is underway and completion is anticipated for Q4, 2024.